LYAR and ovarian cancer: A gene expression profile study with whole blood cell mRNA from ovarian cancer patients revealed LYAR and other five genes (PDIA3, NOP14, NCALD, MTSS1 and CYP1B1) as potential prognostic biomarkers for curative and postoperative supportive therapies for ovarian cancer [11].